Best TWAS P=1.05e-11 · Best GWAS P=1.6e-10 conditioned to 0.00026
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | FAM109B | 0.06 | 0.02 | blup | 337 | 0.03 | 7.4e-05 | -5.1 | 5.6 | 2.6e-08 | 0.01 | 0.10 | 0.90 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | MCHR1 | 0.15 | 0.07 | lasso | 7 | 0.14 | 7.5e-17 | 5.1 | -6.6 | 3.3e-11 | 0.05 | 0.09 | 0.91 | FALSE |
3 | CommonMind | Brain Pre-frontal Cortex | NAGA | 0.09 | 0.09 | blup | 336 | 0.13 | 1.2e-15 | -5.1 | 5.7 | 1.3e-08 | 0.04 | 0.09 | 0.91 | FALSE |
4 | CommonMind | Brain Pre-frontal Cortex | SLC25A17 | 0.03 | 0.01 | blup | 301 | 0.01 | 9.6e-03 | 5.4 | -5.1 | 3.1e-07 | 0.11 | 0.07 | 0.66 | FALSE |
5 | CommonMind | Brain Pre-frontal Cortex | XPNPEP3 | 0.06 | 0.04 | lasso | 4 | 0.04 | 3.9e-06 | -5.3 | 5.8 | 7.6e-09 | -0.11 | 0.06 | 0.94 | FALSE |
6 | GTEx | Artery Aorta | L3MBTL2 | 0.14 | 0.01 | lasso | 6 | 0.04 | 1.8e-03 | -5.1 | 6.2 | 6.6e-10 | -0.11 | 0.03 | 0.88 | FALSE |
7 | GTEx | Breast Mammary Tissue (Female) | ST13 | 0.06 | 0.05 | enet | 1 | 0.02 | 9.3e-02 | -5.3 | 5.3 | 1.1e-07 | -0.10 | 0.04 | 0.25 | FALSE |
8 | GTEx | Cells EBV-transformed lymphocytes | CYP2D6 | 0.25 | 0.16 | lasso | 7 | 0.12 | 7.7e-05 | 4.8 | -5.2 | 2.5e-07 | -0.05 | 0.06 | 0.92 | FALSE |
9 | GTEx | Cells Transformed fibroblasts | SLC25A17 | 0.09 | 0.03 | enet | 10 | 0.06 | 4.2e-05 | 5.0 | 5.8 | 6.7e-09 | -0.09 | 0.08 | 0.91 | FALSE |
10 | GTEx | Esophagus Muscularis | MGAT3 | 0.09 | 0.02 | enet | 15 | 0.02 | 1.3e-02 | 5.5 | -5.8 | 6.8e-09 | -0.70 | 0.10 | 0.53 | TRUE |
11 | GTEx | Liver | OLA1P1 | 0.37 | 0.40 | lasso | 1 | 0.35 | 1.7e-10 | 5.3 | 5.3 | 8.9e-08 | 0.04 | 0.02 | 0.98 | FALSE |
12 | GTEx | Liver | NDUFA6-AS1 | 0.38 | 0.25 | enet | 12 | 0.28 | 2.0e-08 | 5.3 | 5.2 | 2.3e-07 | 0.04 | 0.03 | 0.96 | FALSE |
13 | GTEx | Lung | CYP2D7P1 | 0.20 | 0.00 | lasso | 8 | 0.00 | 4.2e-01 | 4.7 | 5.2 | 2.2e-07 | 0.07 | 0.06 | 0.26 | FALSE |
14 | GTEx | Muscle Skeletal | SMDT1 | 0.17 | 0.26 | enet | 17 | 0.28 | 1.3e-27 | -5.0 | 5.2 | 1.7e-07 | 0.02 | 0.09 | 0.90 | FALSE |
15 | GTEx | Nerve Tibial | XPNPEP3 | 0.18 | 0.02 | lasso | 14 | 0.05 | 9.8e-05 | -4.7 | 6.8 | 1.0e-11 | -0.04 | 0.39 | 0.55 | TRUE |
16 | GTEx | Pituitary | NAGA | 0.25 | 0.16 | lasso | 4 | 0.08 | 4.6e-03 | 5.0 | 5.2 | 2.2e-07 | 0.02 | 0.04 | 0.78 | FALSE |
17 | GTEx | Skin Not Sun Exposed Suprapubic | NAGA | 0.13 | 0.06 | lasso | 3 | 0.07 | 1.4e-04 | 5.3 | 6.0 | 2.2e-09 | 0.01 | 0.02 | 0.89 | TRUE |
18 | GTEx | Skin Sun Exposed Lower leg | CYP2D6 | 0.38 | 0.45 | lasso | 9 | 0.46 | 5.8e-42 | 5.3 | -5.4 | 7.2e-08 | -0.04 | 0.03 | 0.97 | FALSE |
19 | GTEx | Spleen | CYP2D6 | 0.60 | 0.50 | lasso | 12 | 0.56 | 2.7e-17 | 4.7 | -5.4 | 6.7e-08 | -0.04 | 0.07 | 0.92 | FALSE |
20 | GTEx | Spleen | CYP2D7P1 | 0.17 | 0.00 | lasso | 3 | 0.03 | 4.8e-02 | 3.3 | 5.2 | 2.3e-07 | 0.08 | 0.05 | 0.41 | FALSE |
21 | GTEx | Stomach | CYP2D7P1 | 0.22 | 0.10 | lasso | 14 | 0.07 | 2.7e-04 | -4.9 | 5.6 | 2.4e-08 | 0.05 | 0.06 | 0.88 | FALSE |
22 | GTEx | Testis | RP4-669P10.16 | 0.35 | 0.33 | enet | 28 | 0.36 | 8.9e-17 | -5.0 | 5.3 | 1.1e-07 | 0.01 | 0.09 | 0.91 | FALSE |
23 | GTEx | Thyroid | FAM109B | 0.07 | 0.06 | lasso | 9 | 0.05 | 2.1e-04 | -5.0 | 5.1 | 2.9e-07 | 0.01 | 0.10 | 0.89 | FALSE |
24 | GTEx | Thyroid | NAGA | 0.10 | 0.17 | lasso | 5 | 0.17 | 9.8e-13 | 5.3 | 5.5 | 3.5e-08 | 0.04 | 0.02 | 0.98 | FALSE |
25 | GTEx | Vagina | CYP2D6 | 0.19 | 0.08 | enet | 14 | 0.08 | 6.8e-03 | 5.3 | -5.7 | 9.6e-09 | -0.04 | 0.04 | 0.77 | FALSE |
26 | GTEx | Whole Blood | FAM109B | 0.04 | 0.06 | lasso | 2 | 0.06 | 3.9e-06 | -4.9 | 5.2 | 2.4e-07 | -0.02 | 0.11 | 0.88 | FALSE |
27 | ROSMAP | Brain Pre-frontal Cortex | NAGA | 0.08 | 0.10 | lasso | 4 | 0.09 | 7.3e-12 | 5.1 | 5.2 | 1.7e-07 | 0.02 | 0.05 | 0.94 | FALSE |
28 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | FAM109B | 0.03 | 0.03 | enet | 3 | 0.02 | 5.4e-03 | -5.0 | 5.2 | 2.6e-07 | -0.01 | 0.01 | 0.82 | FALSE |
29 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | NAGA | 0.04 | 0.07 | enet | 3 | 0.07 | 1.1e-06 | -5.0 | 5.4 | 6.1e-08 | 0.00 | 0.01 | 0.98 | FALSE |
30 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | XPNPEP3 | 0.07 | 0.05 | enet | 6 | 0.07 | 1.2e-06 | 4.8 | 5.8 | 7.8e-09 | -0.09 | 0.01 | 0.99 | FALSE |
31 | The Cancer Genome Atlas | Breast Invasive Carcinoma | NAGA | 0.03 | 0.03 | lasso | 2 | 0.03 | 1.2e-07 | 5.0 | 5.5 | 4.9e-08 | 0.01 | 0.01 | 0.99 | FALSE |
32 | The Cancer Genome Atlas | Colon Adenocarcinoma | NAGA | 0.09 | 0.09 | enet | 7 | 0.11 | 7.0e-07 | 5.0 | 6.0 | 2.7e-09 | 0.00 | 0.01 | 0.98 | FALSE |
33 | The Cancer Genome Atlas | Colon Adenocarcinoma | XPNPEP3 | 0.10 | 0.06 | lasso | 3 | 0.06 | 1.4e-04 | -5.1 | 5.3 | 1.0e-07 | -0.07 | 0.00 | 0.97 | FALSE |
34 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | XPNPEP3 | 0.10 | 0.10 | lasso | 3 | 0.10 | 1.9e-11 | -5.3 | 5.2 | 2.4e-07 | -0.10 | 0.00 | 1.00 | FALSE |
35 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | NAGA | 0.01 | 0.00 | blup | 18 | 0.01 | 5.4e-02 | -5.1 | 5.5 | 4.2e-08 | 0.01 | 0.01 | 0.61 | FALSE |
36 | The Cancer Genome Atlas | Brain Lower Grade Glioma | NAGA | 0.04 | 0.03 | enet | 16 | 0.05 | 6.3e-06 | 4.7 | 5.3 | 9.5e-08 | 0.02 | 0.02 | 0.98 | FALSE |
37 | The Cancer Genome Atlas | Brain Lower Grade Glioma | XPNPEP3 | 0.23 | 0.26 | lasso | 2 | 0.26 | 3.2e-29 | -5.3 | 5.3 | 1.0e-07 | -0.10 | 0.00 | 1.00 | FALSE |
38 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | XPNPEP3 | 0.12 | 0.10 | lasso | 3 | 0.09 | 7.5e-05 | -5.3 | 5.2 | 2.5e-07 | -0.11 | 0.00 | 1.00 | FALSE |
39 | The Cancer Genome Atlas | Lung Adenocarcinoma | NAGA | 0.02 | 0.00 | blup | 18 | 0.01 | 1.5e-02 | -5.1 | 5.7 | 1.0e-08 | 0.01 | 0.01 | 0.73 | FALSE |
40 | The Cancer Genome Atlas | Lung Adenocarcinoma | XPNPEP3 | 0.10 | 0.11 | lasso | 4 | 0.10 | 1.2e-11 | -5.3 | 5.2 | 1.5e-07 | -0.10 | 0.00 | 1.00 | FALSE |
41 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | SLC25A17 | 0.17 | 0.05 | lasso | 4 | 0.05 | 5.0e-04 | -4.6 | 5.9 | 3.4e-09 | 0.00 | 0.03 | 0.41 | FALSE |
42 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | XPNPEP3 | 0.21 | 0.19 | lasso | 1 | 0.19 | 7.2e-08 | -5.3 | 5.3 | 1.1e-07 | -0.10 | 0.00 | 1.00 | FALSE |
43 | The Cancer Genome Atlas | Prostate Adenocarcinoma | NAGA | 0.07 | 0.07 | blup | 18 | 0.10 | 2.0e-10 | 4.7 | 5.2 | 1.6e-07 | 0.03 | 0.02 | 0.98 | FALSE |
44 | The Cancer Genome Atlas | Prostate Adenocarcinoma | XPNPEP3 | 0.18 | 0.15 | enet | 7 | 0.15 | 4.4e-15 | -5.3 | 5.4 | 6.2e-08 | -0.10 | 0.00 | 1.00 | FALSE |
45 | The Cancer Genome Atlas | Stomach Adenocarcinoma | RANGAP1 | 0.19 | 0.04 | enet | 10 | 0.05 | 2.8e-04 | 5.3 | 5.3 | 1.1e-07 | -0.06 | 0.00 | 0.92 | FALSE |
46 | The Cancer Genome Atlas | Thyroid Carcinoma | XPNPEP3 | 0.33 | 0.38 | lasso | 4 | 0.40 | 7.4e-41 | -5.3 | 5.3 | 1.3e-07 | -0.09 | 0.00 | 1.00 | FALSE |